The FDA has approved a new Pfizer meningococcal vaccine whose simpler dosing schedule is expected to make it easier for children and young adults to get fully vaccinated to protect against a rare ...

Please provide your email address to receive an email when new articles are posted on . Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss ...

During its September 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the go-ahead for Penbraya (Pfizer) — meningococcal groups A, C, W, Y ...

Add Yahoo as a preferred source to see more of our stories on Google. A new vaccine from Pfizer has been approved by the Food and Drug Administration as the first shot of its kind to address multiple ...

The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), according to a press ...

The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug Administration ...

The US Food and Drug Administration has approved a meningococcal vaccine against the five most common serogroups causing disease in children and young adults. The new formulation called Penbraya is ...

GSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization Practices (“ACIP”) voted favorably, recommending the use of Penmenvy ...

Free MenB jabs are now available at pharmacies for students starting university this autumn. An expert answers key questions.

Please provide your email address to receive an email when new articles are posted on . The FDA will review GSK’s five-in-one meningococcal vaccine candidate for approval. The agency has already ...